Cost of Pemigatinib 13.5mg

Pemigatinib (Pemigatinib) is used to treat cholangiocarcinoma (CCA) that has spread or cannot be removed with surgery, in people who have tried cancer treatments before and have a certain type of disease in their cancer. type of abnormality in the FGFR2 gene; also used to treat myeloid/lymphoid tumors (blood cancers) that come back or do not respond to treatment in patients who have certain types of abnormalities in the FGFR1 gene in their cancer. Doctors will test the patient's cancer to see if this gene is present.

Pemetinib is an anti-tumor (cancer) drug that interferes with the growth of cancer cells, which are eventually destroyed by the body. This medicine is only available with a doctor's prescription. Pemetinib has a manageable safety profile. In the Phase I FIGHT-101 trial, the most common grade ≥3 adverse events were hyponatremia and pneumonia, with no dose-limiting toxicities observed, and the rate of treatment discontinuation due to adverse events was 10.2%.

The original drug Pemetinib has been launched in China. Due to its short time on the market, it has not yet entered the scope of medical insurance. The price of each box of 9mg*14 tablets may be around 50,000 yuan, which is expensive. The original drug Pemetinib currently on the market overseas, with a specification of 13.5mg*14 tablets, may cost around RMB 70,000 per box (the price may fluctuate due to exchange rates). There are also generic pemetinib drugs produced in other countries overseas, and their drug ingredients are basically the same as those of the original drugs sold abroad. For example, the price of 4.5mg*14 tablets per box produced by a Laos pharmaceutical factory may be around 1,000 yuan (the price may fluctuate due to exchange rates).